RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 14.29 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $563.000 thousand which beat the analyst consensus estimate of $463.250 thousand by 21.53 percent. This is a 185.79 percent increase over sales of $197.000 thousand the same period last year.